Cover Image
市場調查報告書

肌躍症:全球臨床實驗檢討

Myoclonus Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 308784
出版日期 內容資訊 英文 71 Pages
訂單完成後即時交付
價格
Back to Top
肌躍症:全球臨床實驗檢討 Myoclonus Global Clinical Trials Review, H2, 2014
出版日期: 2014年07月21日 內容資訊: 英文 71 Pages
簡介

本報告提供肌躍症相關臨床研究最新趨勢分析,提供您疾病治療方法概要,及臨床實驗的主要國家──G7各國及E7(新興7個國家)的臨床實驗數及實驗對象採用狀況,地區、Phase、階段別的進展,有潛力的贊助商,各企業研究機關的研究進展及有潛力藥劑的比較等資訊。

簡介

  • 肌躍症
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要5個國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量

G7各國臨床實驗數量:中樞神經系統臨床實驗數量中,肌躍症臨床實驗數量所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:中樞神經系統臨床實驗數量中,肌躍症臨床實驗數量所佔的比例

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

肌躍症治療藥臨床實驗的主要參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Taro Pharmaceutical Industries Ltd.
  • 有代表性的研究機關·醫院臨床實驗概要
    • National Pediatric Myoclonus Center
    • Nanjing Medical University
    • First Affiliated Hospital of Henan College
    • Foundation IRCCS Neurological Institute Carlo Besta
    • Hospital Sant Joan de Deu Barcelona
    • National Institute of Neurological Disorders and Stroke
    • Assistance Publique - Hopitaux de Paris
    • Academic Medical Center
    • Mashhad University of Medical Sciences
    • Institut Curie

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2252CTIDB

GlobalData's clinical trial report, "Myoclonus Global Clinical Trials Review, H2, 2014" provides data on the Myoclonus clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myoclonus. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Myoclonus. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Myoclonus
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Myoclonus to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Myoclonus to Central Nervous System Clinical Trials
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Myoclonus
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Myoclonus Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Taro Pharmaceutical Industries Ltd.
      • Clinical Trial Overview of Taro Pharmaceutical Industries Ltd.
    • Clinical Trial Overview of Top Institutes / Government
      • National Pediatric Myoclonus Center
      • Clinical Trial Overview of National Pediatric Myoclonus Center
      • Nanjing Medical University
      • Clinical Trial Overview of Nanjing Medical University
      • First Affiliated Hospital of Henan College
      • Clinical Trial Overview of First Affiliated Hospital of Henan College
      • Foundation IRCCS Neurological Institute Carlo Besta
      • Clinical Trial Overview of Foundation IRCCS Neurological Institute Carlo Besta
      • Hospital Sant Joan de Deu Barcelona
      • Clinical Trial Overview of Hospital Sant Joan de Deu Barcelona
      • National Institute of Neurological Disorders and Stroke
      • Clinical Trial Overview of National Institute of Neurological Disorders and Stroke
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
      • Academic Medical Center
      • Clinical Trial Overview of Academic Medical Center
      • Mashhad University of Medical Sciences
      • Clinical Trial Overview of Mashhad University of Medical Sciences
      • Institut Curie
      • Clinical Trial Overview of Institut Curie
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Myoclonus Therapeutics, Global, Clinical Trials by Region, 2014*
  • Myoclonus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Myoclonus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Myoclonus Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Myoclonus Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Myoclonus Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Myoclonus Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Proportion of Myoclonus to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Myoclonus Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Myoclonus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Myoclonus to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Myoclonus Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Myoclonus Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Myoclonus Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Myoclonus Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Myoclonus Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Myoclonus Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Myoclonus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Myoclonus Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Myoclonus Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Myoclonus Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Myoclonus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by Taro Pharmaceutical Industries Ltd., 2014*
  • Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by National Pediatric Myoclonus Center, 2014*
  • Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by Nanjing Medical University, 2014*
  • Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by First Affiliated Hospital of Henan College, 2014*
  • Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by Foundation IRCCS Neurological Institute Carlo Besta, 2014*
  • Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Sant Joan de Deu Barcelona, 2014*
  • Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014*
  • Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014*
  • Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2014*
  • Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by Mashhad University of Medical Sciences, 2014*
  • Myoclonus Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut Curie, 2014*

List of Figures

  • Myoclonus Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Myoclonus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Myoclonus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Myoclonus Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Myoclonus Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Myoclonus Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of Myoclonus to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Myoclonus Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Myoclonus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Myoclonus to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Myoclonus Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Myoclonus Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Myoclonus Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Myoclonus Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Myoclonus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Myoclonus Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Myoclonus Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Myoclonus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top